Alzheimer's Drugs Market Predicted to Witness Surge in The Near Future

Healtcareresearch29 Dec, 2021Health

The Alzheimer?s drug development pipeline is characterized by an expanding array of symptomatic treatments and potential disease-modifying therapies in the Alzheimer?s drug market. Biopharmaceutical industries and research institutions world over are relentlessly working toward meeting the vast unmet need of clinically proven disease modifying therapies, let alone curing of dementia. The developments in the Alzheimer?s drug market is albeit relatively slow, as evident in the sleek drug treatment pipeline approved by key regulatory agencies. Nonetheless, a growing number of players in the Alzheimer?s drug market are testing new agents. Particularly, these agents are in phase 2 and phase 3 clinical trials in developing as well as developed nations.